Disclaimer FDA posts safety alerts, public health advisories, press releases and other notices from companies as a service to health professionals, consumers and other interested parties. Although FDA approves medical products, FDA does not endorse either the product or the company.



 

This is the retyped text of a public health warning from the California Department of Health Services. Contact the California Department of Health Services for a copy of any referenced enclosures.


   News Release
                CALIFORNIA DEPARTMENT OF HEALTH SERVICES


NUMBER: 09-00                                                           DATE: February 15, 2000
FOR RELEASE: IMMEDIATE                                        CONTACT: Ken August
http://www.dhs.ca.gov                                                                                                                       or Lea Brooks
                                                                                                 (916) 657-3064
 
 

STATE HEALTH DIRECTOR WARNS CONSUMERS ABOUT PRESCRIPTION DRUGS IN HERBAL PRODUCTS


 


SACRAMENTO – Consumers should immediately stop using five herbal products because they contain two prescription drugs not listed as ingredients that are unsafe without monitoring by a physician, State Health Director Diana Bontá, R.N., Dr. P.H., said today. The products are Diabetes Hypoglucose Capsules, Pearl Hypoglycemic Capsules, Tongyi Tang Diabetes Angel Pearl Hypoglycemic Capsules, Tongyi Tang Diabetes Angel Hypoglycemic Capsules and Zhen Qi Capsules.

The products claim to contain only natural Chinese herbal ingredients. However, an investigation by the California Department of Health Services' Food and Drug Branch determined they contain the prescription drugs glyburide and phenformin, which can be used to treat diabetes.

The investigation was launched after a diabetic patient in Northern California suffered from several episodes of low blood sugar after consuming one of the products, Diabetes Hypoglucose Capsules. The patient has fully recovered.

Consumers should stop using these products and seek medical advice, especially if they are currently being treated with other anti-diabetes drugs or if they have symptoms of fatigue, excessive hunger, profuse sweating or numbness of extremities. Consumers who use these products can receive a dangerously high amount of glyburide and phenformin.

These products are available from mail order and can be purchased by telephone or via the Internet:

Consumers should return these products to the seller or dispose of them safely to prevent exposure to children. The Food and Drug Branch is working closely with the U.S. Food and Drug Administration to stop importation of the products into the United States and remove them from sale.
 
 


Return to Summary




 


Return to MedWatchHome PageYour Comments PleaseReturn to Safety IssuesPage

[FDA Home Page]